According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.
According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.
Researchers from Boston University’s Slone Epidemiology Center used prospective data from the Black Women’s Health Study on 44,708 African-American women aged 30 years or older at the time of enrollment to assess vigorous exercise in relation to the overall incidence of invasive breast cancer (n = 1364), estrogen receptor-positive cancer (n = 688), and estrogen receptor(ER)-negative cancer (n =405). More than 307,672 person years of follow-up were studied and Cox proportional hazards models were used to estimated incidence rate ratios (IRR) and 95% confidence intervals (CI).
Editorial: What's next with the morcellation controversy?
Vigorous exercise at baseline and brisk walking for at least 7 hours per week were inversely associated with overall breast cancer incidence (P trend = 0.05):the IRR for ≥7 hour/week relative to <1 hour/week was 0.74 (95% CI 0.57-0.96). ER status had no impact on the association. Breast cancer incidence was not associated with vigorous exercise in high school or at ages 21 or 30. Interestingly, significant periods of inactivity, such as watching television or sitting for long periods while at work, were not significantly associated with breast cancer incidence.
Investigators concluded that a high level of vigorous exercise could be associated with a reduced incidence of breast cancer in African-American women. They believe that the findings could provide information on a potentially modifiable risk factor.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More